Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in the Succinate Dehydrogenase Subunit B Gene
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
CONTEXT: Patients with adrenal and extra-adrenal abdominal paraganglioma (PGL) almost invariably have increased plasma and urine concentrations of metanephrines, the O-methylated metabolites of catecholamines. We report four cases of biochemically silent abdominal PGL, in which metanephrines were normal despite extensive disease. OBJECTIVE: Our objective was to identify the mechanism underlying the lack of catecholamine hypersecretion and metabolism to metanephrines in biochemically silent PGL. DESIGN: This is a descriptive study. SETTING: The study was performed at a referral center. PATIENTS: One index case and three additional patients with large abdominal PGL and metastases but with the lack of evidence of catecholamine production, six patients with metastatic catecholamine-producing PGL and a mutation of the succinate dehydrogenase subunit B (SDHB) gene, and 136 random patients with catecholamine-producing PGL were included in the study. MAIN OUTCOME MEASURES: Plasma, urine, and tumor tissue concentrations of catecholamines and metabolites were calculated with electron microscopy and tyrosine hydroxylase immunohistochemistry. RESULTS: All four patients with biochemically silent PGL had an underlying SDHB mutation. In the index case, the tumor tissue concentration of catecholamines (1.8 nmol/g) was less than 0.01% that of the median (20,410 nmol/g) for the 136 patients with catecholamine-producing tumors. Electron microscopy showed the presence of normal secretory granules in all four biochemically silent PGLs. Tyrosine hydroxylase immunoreactivity was negligible in the four biochemically silent PGLs but abundant in catecholamine-producing PGLs. CONCLUSIONS: Patients with SDHB mutations may present with biochemically silent abdominal PGLs due to defective catecholamine synthesis resulting from the absence of tyrosine hydroxylase. Screening for tumors in patients with SDHB mutations should not be limited to biochemical tests of catecholamine excess.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Self-citation
Research works printed but not linked: 23
- Crout, 1964, Turnover and metabolism of catecholamines in patients with pheochromocytoma., J Clin Invest, 43, 94, 10.1172/JCI104898 · DOI · Paper page
- Eisenhofer, 2005, Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines., Clin Chem, 51, 735, 10.1373/clinchem.2004.045484 · DOI · Paper page
- Eisenhofer, 2005, Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine., J Clin Endocrinol Metab, 90, 2068, 10.1210/jc.2004-2025 · DOI · Paper page
- Proye, 1986, Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion., Surgery, 100, 1154
- Erickson, 2001, Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients., J Clin Endocrinol Metab, 86, 5210, 10.1210/jcem.86.11.8034 · doi:10.1210/jcem.86.11.8034 · Paper page
- Bonnet, 2006, [Malignant hereditary paraganglioma: problems raised by non-functional forms management], Ann Chir, 131, 626, 10.1016/j.anchir.2006.05.004 · DOI
- Holden, 1995, Non-functional malignant extra-adrenal retroperitoneal paraganglioma., Australas Radiol, 39, 392, 10.1111/j.1440-1673.1995.tb00319.x · doi:10.1111/j.1440-1673.1995.tb00319.x
- Louafy, 2001, [Non-functional retroperitoneal paraganglioma], Prog Urol, 11, 512
- Timmers, 2007, Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas., J Clin Endocrinol Metab, 92, 779, 10.1210/jc.2006-2315 · DOI · Paper page
- Olson, 1969, Nonfunctional, nonchromaffin paragangliomas of the retroperitoneum., Cancer, 23, 1358, 10.1002/1097-0142(196906)23:6<1358::AID-CNCR2820230618>3.0.CO;2-# · doi:10.1002/1097-0142(196906)23:6<1358::aid-cncr2820230618>3.0.co;2-#
- Unger, 2006, Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass., Eur J Endocrinol, 154, 409, 10.1530/eje.1.02097 · DOI · Paper page
- Willemsen, 2003, Stability of plasma free metanephrines during collection and storage as assessed by an optimized HPLC method with electrochemical detection., Clin Chem, 49, 1951, 10.1373/clinchem.2003.023135 · DOI · Paper page
- Lenders, 1993, Determination of metanephrines in plasma by liquid chromatography with electrochemical detection., Clin Chem, 39, 97, 10.1093/clinchem/39.1.97 · DOI · Paper page
- Eisenhofer, 1986, Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase., Clin Chem, 32, 2030, 10.1093/clinchem/32.11.2030 · DOI · Paper page
- Nagatsu, 1964, Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis., J Biol Chem, 239, 2910, 10.1016/S0021-9258(18)93832-9 · DOI · Paper page
- Huynh, 2005, Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2., Eur J Endocrinol, 153, 551, 10.1530/eje.1.01987 · DOI · Paper page
- Koch, 2002, New insights into the genetics of familial chromaffin cell tumors., Ann NY Acad Sci, 970, 11, 10.1111/j.1749-6632.2002.tb04409.x · DOI
- Hillarp, 1955, Histochemical demonstration of noradrenaline and adrenaline in the adrenal medulla., J Histochem Cytochem, 3, 1, 10.1177/3.1.1 · doi:10.1177/3.1.1
- Takahashi, 1987, Paragangliomas of the craniocervical region. An immunohistochemical study on tyrosine hydroxylase., Acta Neuropathol, 73, 227, 10.1007/BF00686615 · doi:10.1007/bf00686615
- Brady, 1997, Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: case report with immunohistochemical analysis., Am J Surg Pathol, 21, 102, 10.1097/00000478-199701000-00011 · doi:10.1097/00000478-199701000-00011
- Cleary, 2005, Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma., Cell Tissue Res, 322, 443, 10.1007/s00441-005-0026-y · DOI
- Meijer, 2003, Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas., Clin Chem, 49, 586, 10.1373/49.4.586 · doi:10.1373/49.4.586
- Chou, 1998, Ultrastructural and biochemical characterization of catecholamine release mechanisms in cultured human pheochromocytoma cells., Chin Med J (Engl), 111, 1018
Cited by
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Self-citationOverview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas
Mete, O., Asa, S. L., Gill, A. J., Kimura, N., de Krijger, R. R., & Tischler, A. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09704-6 · Cited by 424
Personalized Management of Pheochromocytoma and Paraganglioma
Nölting, S., Bechmann, N., Taieb, D., Beuschlein, F., Fassnacht, M., Kroiss, M., Eisenhofer, G., Grossman, A., & Pacak, K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab019 · Cited by 417
Self-citationNew Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Crona, J., Taïeb, D., & Pacak, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 324
Self-citationWaguespack, S. G., Rich, T., Grubbs, E., Ying, A. K., Perrier, N. D., Ayala-Ramirez, M., & Jimenez, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2830 · Cited by 232
Metadata
- Authors
- Timmers, H. J. L. M., Pacak, K., Huynh, T. T., Abu-Asab, M., Tsokos, M., Merino, M. J., Baysal, B. E., Adams, K. T., & Eisenhofer, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12-01
- Volume
- 93
- Issue
- 12
- Pages
- 4826-4832
- ISSN
- 0021-972X
- 1945-7197
- Cited by
- 114
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.